Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Palacios

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Pacing and Clinical Electrophysiology : PACE|May 6, 2015
Incidence and Predictors of Pacemaker Implantation in Patients Undergoing Transcatheter Aortic Valve ReplacementAbhishek Maan, Marwan M Refaat, Edwin Kevin Heist, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 30, 2019
Impella support and acute kidney injury during high-risk percutaneous coronary intervention: The Global cVAD Renal Protection StudyMichael P Flaherty, Jeffrey W Moses, Ralf Westenfeld, et al.
Pharmacology & Therapeutics|March 27, 2013
The brain's heart - therapeutic opportunities for patent foramen ovale (PFO) and neurovascular diseaseMingming Ning, Eng H Lo, Pei-Chen Ning, et al.
American Heart Journal|November 7, 2015
Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experienceMauricio G Cohen, Ray Matthews, Brij Maini, et al.
The American Journal of Cardiology|February 18, 2014
Comparison of cost-effectiveness of oral rapamycin plus bare-metal stents versus first generation of drug-eluting stents (from the Randomized Oral Rapamycin in Argentina [ORAR] 3 trial)Alfredo E Rodriguez, Igor Palacios, Alfredo M Rodriguez-Granillo, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|November 6, 2012
Percutaneous coronary intervention vs. coronary artery bypass graft surgery for unprotected left main coronary artery disease in the drug-eluting stents era--an aggregate data meta-analysis of 11,148 patientsMahboob Alam, Henry D Huang, Saima A Shahzad, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
Revascularization strategies of coronary multiple vessel disease in the Drug Eluting Stent Era: one year follow-up results of the ERACI III TrialAlfredo E Rodriguez, Liliana Grinfeld, Carlos Fernandez-Pereira, et al.
Circulation|January 4, 2007
Images in cardiovascular medicine. Left main coronary artery compression syndrome: evaluation with 64-slice cardiac multidetector computed tomographyJonathan D Dodd, Andrew Maree, Igor Palacios, et al.
JACC. Cardiovascular Interventions|October 12, 2019
The Value of Left Ventricular Support in Patients With Reduced Left Ventricular Function Undergoing Extensive Revascularization: An Analysis From the PROTECT-II Randomized TrialDavid A Burke, Harun Kundi, Alexandra Almonacid, et al.
Circulation|September 1, 2012
A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II studyWilliam W O'Neill, Neal S Kleiman, Jeffrey Moses, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Pacing and Clinical Electrophysiology : PACE|May 6, 2015
Incidence and Predictors of Pacemaker Implantation in Patients Undergoing Transcatheter Aortic Valve ReplacementAbhishek Maan, Marwan M Refaat, Edwin Kevin Heist, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 30, 2019
Impella support and acute kidney injury during high-risk percutaneous coronary intervention: The Global cVAD Renal Protection StudyMichael P Flaherty, Jeffrey W Moses, Ralf Westenfeld, et al.
Pharmacology & Therapeutics|March 27, 2013
The brain's heart - therapeutic opportunities for patent foramen ovale (PFO) and neurovascular diseaseMingming Ning, Eng H Lo, Pei-Chen Ning, et al.
American Heart Journal|November 7, 2015
Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experienceMauricio G Cohen, Ray Matthews, Brij Maini, et al.
The American Journal of Cardiology|February 18, 2014
Comparison of cost-effectiveness of oral rapamycin plus bare-metal stents versus first generation of drug-eluting stents (from the Randomized Oral Rapamycin in Argentina [ORAR] 3 trial)Alfredo E Rodriguez, Igor Palacios, Alfredo M Rodriguez-Granillo, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|November 6, 2012
Percutaneous coronary intervention vs. coronary artery bypass graft surgery for unprotected left main coronary artery disease in the drug-eluting stents era--an aggregate data meta-analysis of 11,148 patientsMahboob Alam, Henry D Huang, Saima A Shahzad, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
Revascularization strategies of coronary multiple vessel disease in the Drug Eluting Stent Era: one year follow-up results of the ERACI III TrialAlfredo E Rodriguez, Liliana Grinfeld, Carlos Fernandez-Pereira, et al.
Circulation|January 4, 2007
Images in cardiovascular medicine. Left main coronary artery compression syndrome: evaluation with 64-slice cardiac multidetector computed tomographyJonathan D Dodd, Andrew Maree, Igor Palacios, et al.
JACC. Cardiovascular Interventions|October 12, 2019
The Value of Left Ventricular Support in Patients With Reduced Left Ventricular Function Undergoing Extensive Revascularization: An Analysis From the PROTECT-II Randomized TrialDavid A Burke, Harun Kundi, Alexandra Almonacid, et al.
Circulation|September 1, 2012
A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II studyWilliam W O'Neill, Neal S Kleiman, Jeffrey Moses, et al.
Pageof 6